Richard D. Tillyer

Statistics

Publications

Citations

2.3K

H-Index

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Biopharma Co., Ltd. (Japan)

University of Cambridge

Merck Canada Inc. (Canada)

Nihon Fukushi University

Richard D. Tillyer is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in chemistry, medicinal chemistry, and organic chemistry.

ORCID

Publications per year

1988–2006

Publications

Highly Efficient Synthesis of β-Amino Acid Derivatives via Asymmetric Hydrogenation of Unprotected Enamines

Yi Hsiao, Nelo R. Rivera, Thorsten Rosner et al. · Journal of the American Chemical Society · 2004 · 249 citations

Natural Sciences, Chemistry, Medicinal Chemistry +11

Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor

Michael E. Pierce, Rodney L. Parsons, Lilian Radesca et al. · The Journal of Organic Chemistry · 1998 · 215 citations

Pharmacy, Chemistry, Medicinal Chemistry +16

A Novel, Highly Enantioselective Ketone Alkynylation Reaction Mediated by Chiral Zinc Aminoalkoxides

Lushi Tan, Cheng‐Yi Chen, Richard D. Tillyer et al. · Angewandte Chemie International Edition · 1999 · 185 citations

Pharmacy, Chemistry, Medicinal Chemistry +13

Synthesis of Substituted Imidazoles via Organocatalysis

Doug E. Frantz, Louis Morency, Arash Soheili et al. · Organic Letters · 2004 · 169 citations

Natural Sciences, Chemistry, Medicinal Chemistry +15

A General Synthesis of Substituted Indoles from Cyclic Enol Ethers and Enol Lactones

Kevin R. Campos, Jacqueline C. S. Woo, Sandra Lee et al. · Organic Letters · 2003 · 116 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12

1–5 of 36